Determinan perilaku deteksi dini kanker serviks terhadap implementasi co-testing HPV DNA dan IVA di negara berkembang: Sebuah tinjauan sistematis
DOI: https://doi.org/10.33024/hjk.v20i5.3158
Cervical Cancer Screening Behavior Co-Testing Developing Countries Early Detection Behavioral Determinants HPV DNA Testing Uptake Visual Inspection Acetic Acid
Abstract
Background: Cervical cancer remains a major public health concern in developing countries, where screening coverage is still low. Co-testing HPV DNA and IVA/VIA has the potential to improve early detection; however, its success is influenced by women's behavior in accessing and completing the screening pathway.
Purpose: To identify the determinants of early cervical cancer detection behavior among women in developing countries in the context of co-testing HPV DNA and IVA implementation.
Method: A systematic literature review based on the PICCO framework was conducted. ework. Articles reviewed included studies on HPV DNA testing and IVA/VIA/visual inspection within a single screening algorithm, either as co-testing, concurrent testing, HPV primary screening followed by VIA triage, or screen–triage–treat. Study quality was assessed using JBI Critical Appraisal Tools, and data were synthesized narratively based on individual, social, healthcare service, economic, and cultural factors.
Results: Ten primary studies were analyzed. Dominant determinants included knowledge, risk perception, acceptance of screening methods, stigma, partner/family support, transportation costs, service distance, informal employment, geographic access, follow-up systems, number of visits, HPV DNA result turnaround time, and availability of IVA/VIA triage on the same day. HPV self-sampling, single-visit services, community-based approaches, and active recall systems have the potential to increase uptake and reduce loss to follow-up.
Conclusion: Behavioral determinants of early cervical cancer detection in the context of co-testing HPV DNA and IVA are multidimensional. Screening programs in developing countries need to integrate education, community-based approaches, easy service access, rapid triage, and active follow-up to increase participation and screening compliance.
Keywords: Cervical Cancer Screening Behavior; Co-Testing Developing Countries; Early Detection Behavioral Determinants; HPV DNA Testing Uptake; Visual Inspection Acetic Acid.
Downloads
References
Anggriani, B., Sitorus, R. J., Flora, R., & Octariyana, O. (2023). Perempuan dan penyakit keganasan (kanker payudara dan kanker serviks). Scientific Of Environmental Health and Diseases, 3(1), 131-142.
Ba, D. M., Ssentongo, P., Musa, J., Agbese, E., Diakite, B., Traore, C. B., Wang, S., & Maiga, M. (2021). Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: a population-based study. Cancer epidemiology, 72, 101930.
Brandt, T., Wubneh, S. B., Handebo, S., Debalkie, G., Ayanaw, Y., Alemu, K., Jede, F., Knebel Doeberitz, M., & Bussmann, H. (2019). Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia. BMC Public Health, 19(1), 1026.
Cholli, P., Bradford, L., Manga, S., Nulah, K., Kiyang, E., Manjuh, F., & Ogembo, J. G. (2018). Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: findings of initial screening and one-year follow-up. Gynecologic oncology, 148(1), 118-125.
Effah, K., Allotey, J., Tekpor, E., Wormenor, C. M., Amuah, J. E., Antwi-Boasiako, E., Kotey, E. N., Kemawor, S., Gedzah, I., Frempong, H. M. A., Danyo, S., Sesenu, E., Atuguba, B. H., Essel, N. O. M., & Akakpo, P. K. (2025). Nationwide cervical precancer screening in Ghana: concurrent HPV DNA testing and visual inspection under an expanded hub-and-spoke model. Scientific Reports, 15(1), 1744.
Effah, K., Tekpor, E., Wormenor, C. M., Amuah, J. E., Essel, N. O., Atuguba, B. H., Klutsey, G. B., Sesenu, E., Tay, G., Tibu, F., Kemawor, S., Gedzah, I., Morkli, E. A. C., Danyo, S., & Akakpo, P. K. (2023). Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: a practical approach from Battor, Ghana. PLOS Global Public Health, 3(4), e0001830.
Endarti, D., Kristina, S. A., Farida, M. A., Rahmawanti, Y., & Andriani, T. (2018). Knowledge, perception, and acceptance of HPV vaccination and screening for cervical cancer among women in Yogyakarta Province, Indonesia. Asian Pacific journal of cancer prevention: APJCP, 19(4), 1105.
Gizaw, M., Teka, B., Ruddies, F., Abebe, T., Kaufmann, A. M., Worku, A., Wienke, A., Jemal, A., Addissie, A., & Kantelhardt, E. J. (2019). Uptake of cervical cancer screening in Ethiopia by self-sampling HPV DNA compared to visual inspection with acetic acid: a cluster randomized trial. Cancer Prevention Research, 12(9), 609-616.
Gizaw, M., Teka, B., Ruddies, F., Kassahun, K., Worku, D., Worku, A., Wienke, A., Mikolajczyk, R., Jemal, A., Kaufmann, A. M., Abebe, T., Addissie, A., & Kantelhardt, E. J. (2020). Reasons for not attending cervical cancer screening and associated factors in Rural Ethiopia. Cancer prevention research, 13(7), 593-600.
Gottschlich, A., Payne, B. A., Trawin, J., Albert, A., Jeronimo, J., Mitchell-Foster, S., Mithani, N., Namugosa, R., Naguti, P., Pedersen, H., Rawat, A., Simelela, P. N., Singer, J., Smith, L. W., Niekerk, D., Orem, J., Nakisige, C., & Ogilvie, G. (2023). Community-integrated self-collected HPV-based cervix screening in a low-resource rural setting: a pragmatic, cluster-randomized trial. Nature medicine, 29(4), 927-935.
Idowu, A., Olowookere, S. A., Fagbemi, A. T., & Ogunlaja, O. A. (2016). Determinants of cervical cancer screening uptake among women in Ilorin, north Central Nigeria: a community‐based study. Journal of cancer epidemiology, 2016(1), 6469240.
Krishnamoorthy, Y., Ganesh, K., & Sakthivel, M. (2022). Prevalence and determinants of breast and cervical cancer screening among women aged between 30 and 49 years in India: Secondary data analysis of National Family Health Survey–4. Indian Journal of Cancer, 59(1), 54-64.
Tiruneh, F. N., Chuang, K. Y., Ntenda, P. A. M., & Chuang, Y. C. (2017). Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey. BMC women's health, 17(1), 109.
Umulisa, M. C., Franceschi, S., Baussano, I., Tenet, V., Uwimbabazi, M., Rugwizangoga, B., Heideman, D. A. M., Uyterlinde, A. M., Darragh, T. M., Snijders, P. J. F., Sayinzoga, F., & Clifford, G. M. (2018). Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda. BMC women's health, 18(1), 59.
Visanuyothin, S., Chompikul, J., & Mongkolchati, A. (2015). Determinants of cervical cancer screening adherence in urban areas of Nakhon Ratchasima Province, Thailand. Journal of infection and public health, 8(6), 543-552.
Wang, M., Hu, S., Zhao, S., Zhang, W., Pan, Q., Zhang, X., Chen, F., Han, J., Ma, J., Smith, J. S., Qiao, Y., Zhou, C., & Zhao, F. (2017). Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: a cross-sectional study in China. Chinese Journal of Cancer Research, 29(6), 496.
Wang, S., Dang, L., Liu, S., Rezhake, R., Yan, H., Duan, X., Zhang, L., Zhang, L., Zhang, L., Su, M., Guo, F., Yan, C., Liu, M., Cao, X., Sun, M., Qiao, Y., & Zhao, (2024). Cervical cancer screening via visual inspection with acetic acid and Lugol iodine for triage of HPV-positive women. JAMA network open, 7(3), e244090.
World Health Organization. (2021). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (2nd ed.). World Health Organization. Di akses dari: https://www.who.int/publications/i/item/9789240030824
World Health Organization. (2025). Cervical cancer. Diakses dari: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
World Health Organization. (2025). Cervical cancer elimination initiative. Diakses dari: https://www.who.int/initiatives/cervical-cancer-elimination-initiative
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Holistik Jurnal Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
